beta thalassemia

Image of a crossing guard sign in the foreground with a crossing guard directing traffic in the background
Biotech

FDA advisers wave through first CRISPR-based therapy

After Thursday's advisory committee meeting, CRISPR and Vertex will now wait for an official FDA decision on exa-cel.
Max Bayer Nov 1, 2023 11:07am
photo of a royal flush laid out on the poker table with chips scattered nearby

CRISPR on hunt for pipeline partners and enticing delivery tech

Oct 19, 2023 10:35am
sickle cell blood anemia

Pfizer drops sickle cell collab with Syros inherited from GBT

Jul 24, 2023 10:23am
Step closer race run

Vertex-CRISPR drug posts phase 3 wins, secures PDUFA date

Jun 9, 2023 7:30am
Ionis headquarters

Ionis' midphase misses send rare disease prospects to the abyss

May 4, 2023 10:25am
Vertex

Vertex pays ImmunoGen $15M to pair ADCs with CRISPR therapy

Mar 1, 2023 9:09am